| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.05 | 0.8 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |